JP2020518608A5 - - Google Patents

Download PDF

Info

Publication number
JP2020518608A5
JP2020518608A5 JP2019560139A JP2019560139A JP2020518608A5 JP 2020518608 A5 JP2020518608 A5 JP 2020518608A5 JP 2019560139 A JP2019560139 A JP 2019560139A JP 2019560139 A JP2019560139 A JP 2019560139A JP 2020518608 A5 JP2020518608 A5 JP 2020518608A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
busulfan
cyclodextrin
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019560139A
Other languages
English (en)
Japanese (ja)
Other versions
JP7204670B2 (ja
JP2020518608A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/030728 external-priority patent/WO2018204535A1/en
Publication of JP2020518608A publication Critical patent/JP2020518608A/ja
Publication of JP2020518608A5 publication Critical patent/JP2020518608A5/ja
Priority to JP2022212559A priority Critical patent/JP7597778B2/ja
Application granted granted Critical
Publication of JP7204670B2 publication Critical patent/JP7204670B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019560139A 2017-05-03 2018-05-02 シクロデキストリン及びブスルファンを含有する組成物 Active JP7204670B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022212559A JP7597778B2 (ja) 2017-05-03 2022-12-28 シクロデキストリン及びブスルファンを含有する組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762500970P 2017-05-03 2017-05-03
US62/500,970 2017-05-03
PCT/US2018/030728 WO2018204535A1 (en) 2017-05-03 2018-05-02 Composition containing cyclodextrin and busulfan

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022212559A Division JP7597778B2 (ja) 2017-05-03 2022-12-28 シクロデキストリン及びブスルファンを含有する組成物

Publications (3)

Publication Number Publication Date
JP2020518608A JP2020518608A (ja) 2020-06-25
JP2020518608A5 true JP2020518608A5 (cg-RX-API-DMAC7.html) 2021-06-17
JP7204670B2 JP7204670B2 (ja) 2023-01-16

Family

ID=64014433

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019560139A Active JP7204670B2 (ja) 2017-05-03 2018-05-02 シクロデキストリン及びブスルファンを含有する組成物
JP2022212559A Active JP7597778B2 (ja) 2017-05-03 2022-12-28 シクロデキストリン及びブスルファンを含有する組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022212559A Active JP7597778B2 (ja) 2017-05-03 2022-12-28 シクロデキストリン及びブスルファンを含有する組成物

Country Status (10)

Country Link
US (2) US20180318249A1 (cg-RX-API-DMAC7.html)
EP (1) EP3618825A4 (cg-RX-API-DMAC7.html)
JP (2) JP7204670B2 (cg-RX-API-DMAC7.html)
KR (1) KR20190141244A (cg-RX-API-DMAC7.html)
CN (1) CN110831588B (cg-RX-API-DMAC7.html)
AU (1) AU2018263924B2 (cg-RX-API-DMAC7.html)
BR (1) BR112019023074A2 (cg-RX-API-DMAC7.html)
CA (1) CA3062308A1 (cg-RX-API-DMAC7.html)
MX (2) MX2019013053A (cg-RX-API-DMAC7.html)
WO (1) WO2018204535A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109078005B (zh) * 2018-08-07 2021-11-26 江苏领航生物科技有限公司 一种白消安组合物及其制备方法和应用
CN113679852B (zh) * 2021-09-13 2022-11-15 天津师范大学 一种水溶性主客体复合物及其制备与应用

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3426011A (en) 1967-02-13 1969-02-04 Corn Products Co Cyclodextrins with anionic properties
US4783443A (en) 1986-03-03 1988-11-08 The University Of Chicago Amino acyl cephalosporin derivatives
KR0166088B1 (ko) 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
US5376645A (en) 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
EP0710673A3 (en) 1990-05-21 1996-08-07 Toppan Printing Co Ltd Cyclodextrin derivatives
US5180716A (en) * 1990-08-01 1993-01-19 The Regents Of The University Of California Cyclodextrin complexes for neuraxial administration of drugs
US5430057A (en) 1993-09-30 1995-07-04 Board Of Regents, The University Of Texas System Parenteral busulfan for treatment of malignant disease
US5874418A (en) 1997-05-05 1999-02-23 Cydex, Inc. Sulfoalkyl ether cyclodextrin based solid pharmaceutical formulations and their use
US6046177A (en) 1997-05-05 2000-04-04 Cydex, Inc. Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
EP0889056B1 (en) 1997-07-01 2006-04-12 Pfizer Products Inc. Process for making a cyclodextrin
TWI242015B (en) 1999-11-29 2005-10-21 Akzo Nobel Nv 6-mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block
CN1232539C (zh) * 2002-05-10 2005-12-21 刘云清 有机药物与倍他环糊精衍生物的配合物及其制备方法
JP2006500387A (ja) 2002-08-15 2006-01-05 雲清 劉 固形ナノ医薬およびその調製方法
AU2003275329B2 (en) 2002-09-13 2008-04-03 Cydex Pharmaceuticals, Inc. Capsules containing aqueous fill compositions stabilized with derivatized cyclodextrin
KR20060096490A (ko) 2003-10-31 2006-09-11 더 유니버시티 오브 캔사스 술포알킬 에테르-알킬 에테르 시클로덱스트린 유도체
US20070020196A1 (en) * 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid prepared from a unit dose suspension
ES2364491T5 (es) 2005-10-26 2015-02-19 Cydex Pharmaceuticals, Inc. Composiciones de sulfoalquiléter ciclodextrina y métodos de preparación de las mismas
US7658913B2 (en) * 2005-11-28 2010-02-09 Verrow Pharmaceuticals, Inc. Compositions useful for reducing nephrotoxicity and methods of use thereof
JP2009517402A (ja) 2005-11-28 2009-04-30 ディー. ロウェ,バーノン 腎毒性の低減に有用な組成物及びその使用方法
CN100411688C (zh) * 2006-09-12 2008-08-20 南京师范大学 含有环糊精/多烯紫杉醇包合物的药物组合物及其制备方法
WO2008067027A2 (en) * 2006-10-20 2008-06-05 Icos Corporation Compositions of chkl inhibitors and cyclodextrin
MX357677B (es) * 2009-05-29 2018-07-19 Cydex Pharmaceuticals Inc Composiciones inyectables de melfalán que comprenden un derivado de ciclodextrina y métodos de fabricación y uso de las mismas.
KR20240119191A (ko) * 2012-05-08 2024-08-06 오닉스 세라퓨틱스, 인크. 펩티드 프로테아좀 억제제 제제화를 위한 사이클로덱스트린 복합체화 방법
CN105726467A (zh) * 2014-12-09 2016-07-06 四川科瑞德制药有限公司 一种白消安注射液及其制备方法

Similar Documents

Publication Publication Date Title
JP3689791B2 (ja) タキソイドに基づく新規な組成物
JP6410889B2 (ja) 注射用徐放性製剤
JP5089004B2 (ja) ボリコナゾールを含有する薬剤製剤
JP6218204B2 (ja) カテコール基を有するセファロスポリン類を含有する製剤
JP4202273B2 (ja) フマギロール誘導体又はその塩の包接化合物、及び該包接化合物を含む医薬組成物
FI111808B (fi) Menetelmä uusien, taksaaneihin perustuvien farmaseuttisten koostumusten valmistamiseksi
CN1223347C (zh) 注射用西洛他唑水性制剂
JP2014525449A5 (cg-RX-API-DMAC7.html)
JP2019514955A (ja) 選択的エストロゲン受容体ダウンレギュレーター(serds)
UA124818C2 (uk) Композиція для ін'єкції
JP2020518608A5 (cg-RX-API-DMAC7.html)
RU2008146217A (ru) Фармацевтическая композиция, содержащая производное таксана, которая предназначена для приготовления инфузионного раствора, способ его приготовления и использование
JP6450356B2 (ja) 液状医薬製剤
RU2004133387A (ru) Фармацевтический препарат с немедленным высвобождением
KR101829685B1 (ko) 안정성 및 용해도가 개선된 주사용 조성물
JP7597778B2 (ja) シクロデキストリン及びブスルファンを含有する組成物
WO2011111070A2 (en) Novel injectable combination
RU2678772C2 (ru) Композиция кабазитаксела
RU2013107761A (ru) Фармацевтическая композиция, содержащая триптофановое производное
CN1931368A (zh) 含有环糊精紫杉醇包合物的药物组合物及其制备方法
RU2443432C2 (ru) Фармацевтическая композиция для введения инъекцией
TW201707707A (zh) 包含吲哚化合物之製劑及其製備方法
JP3917820B2 (ja) オザグレルナトリウム含有注射液およびその安定化方法
KR20200059221A (ko) 시포니모드를 포함하는 비경구 제형
JP2017506660A (ja) フルラン複合体を製造するための方法